USPTO serial 79325247
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica S. Sachs
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substance preparations, chemical materials preparations and chemical preparations all for scientific purposes, and chemical elements, namely, chemical elements used in pharmaceuticals for scientific purposes; chemical substances and materials used to enhance the efficacy of biopharmaceuticals for industrial, scientific and laboratory purposes; biochemical substances preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Biochemical reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting and verification use, other than for medical or veterinary purposes; reagents for research use in the development of antibodies, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; antibodies and antibodies-based chemical reagents for non-medical and non-veterinary use | ACTIVE | — |
| 005 | Medical and veterinary preparations and articles, namely, pharmaceutical preparations for half-life extension and enhancement of efficacy of protein therapeutics; pharmaceutical preparations and substances, namely, a pharmaceutical agent consisting of compounds comprised of albumin-binding domains and albumin that facilitate delivery of a wide range of pharmaceuticals; biochemical preparations for medical use for the treatment of systemic and local diseases; biochemical pharmaceutical preparations for medical use for half-life extension and enhancement of efficacy of protein therapeutics; antibodies and antibodies-based pharmaceutical preparations for medical purposes for half-life extension and enhancement of efficacy of protein therapeutics; diagnostic preparations and materials; reagents for medical use; biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; sanitary preparations for medical purposes | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments, namely, medical apparatus and instruments for use in surgery; Diagnostic, examination, and monitoring equipment for medical use, namely, medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical and veterinary apparatus and instruments, namely, Hematology analyzers for medical diagnostic uses; Medical and veterinary apparatus and instruments, namely, Medical diagnostic instruments for the analysis of body fluids; Medical and veterinary apparatus and instruments, namely, X-ray diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for detecting cancer or and inflammation; Medical and veterinary apparatus and instruments, namely, Ultrasonic medical diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for testing DNA and RNA samples; Separation instruments for medical use, namely, blood component separation apparatus for medical purposes; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Gas chromatographic instruments for medical use; Electromagnetic diagnostic imaging apparatus for medical use; Medication fluid injectors for medical use | ACTIVE | — |
| 042 | Scientific and technological services and research, development and design in the fields of half-life extension, pharmacokinetics and pharmacodynamics; medical and pharmacological research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; medical, pharmaceutical and biotechnological laboratory research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; drug discovery services; pharmaceutical products development and evaluation | ACTIVE | — |
| 044 | medical services; providing medical information; physical examination services; medical diagnostic testing, monitoring and reporting services; optical medical imaging services for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 26, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 26, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 11, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 11, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 11, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 24, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 24, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 4, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 16, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 16, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 16, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 29, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 29, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 8, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |